A patient on urinary catheter – catheter tip culture shown extended spectrum b-lactamase +ve Klebsiella. Which of the following drug you can give?
**Core Concept**
Extended-spectrum beta-lactamases (ESBL) are enzymes produced by certain bacteria, including Klebsiella, that confer resistance to a wide range of beta-lactam antibiotics, including penicillins, cephalosporins, and monobactams. This resistance mechanism is a major public health concern, as it limits treatment options for serious infections.
**Why the Correct Answer is Right**
The correct answer is a drug that is not affected by ESBL enzymes. Piperacillin-tazobactam is a carbapenem-sparing antibiotic that combines a broad-spectrum beta-lactam (piperacillin) with a beta-lactamase inhibitor (tazobactam). This combination effectively counteracts the ESBL enzyme, allowing the antibiotic to retain its antimicrobial activity against ESBL-producing bacteria like Klebsiella.
**Why Each Wrong Option is Incorrect**
**Option A:** Cefepime is a fourth-generation cephalosporin, which is generally more stable against ESBL enzymes than earlier cephalosporins. However, it is not always effective against ESBL-producing Klebsiella, and resistance rates can vary.
**Option B:** Ciprofloxacin is a fluoroquinolone antibiotic that is often used to treat urinary tract infections. However, resistance to ciprofloxacin is common among ESBL-producing bacteria, making it an ineffective choice for this patient.
**Option C:** Amikacin is an aminoglycoside antibiotic that can be effective against Klebsiella. However, it is not typically used as a first-line treatment for urinary catheter-associated infections, and its use may be limited by nephrotoxicity and ototoxicity.
**Clinical Pearl / High-Yield Fact**
When treating ESBL-producing bacteria, it is essential to choose an antibiotic that is specifically effective against these organisms. Piperacillin-tazobactam is a useful option in this scenario, but other antibiotics like carbapenems (e.g., meropenem) may also be effective. Always consider local resistance patterns and antibiotic susceptibility testing when selecting an antibiotic for a patient with a serious infection.
**Correct Answer: C. Piperacillin-tazobactam**